119 related articles for article (PubMed ID: 8570083)
1. Learning from the Japanese Registry: how will we prevent long-term complications? Niigata Research Programme for beta 2-M Removal Membrane.
Aoike I; Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10 Suppl 7():7-15. PubMed ID: 8570083
[TBL] [Abstract][Full Text] [Related]
2. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach.
Cianciolo G; Colí L; La Manna G; Donati G; D'Addio F; Comai G; Ricci D; Dormi A; Wratten M; Feliciangeli G; Stefoni S
Int J Artif Organs; 2007 Oct; 30(10):864-78. PubMed ID: 17992647
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical experience with PMMA membrane.
Aoike I
Contrib Nephrol; 1999; 125():205-12. PubMed ID: 9895442
[No Abstract] [Full Text] [Related]
4. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.
Campistol JM; Torregrosa JV; Ponz E; Fenollosa B
Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432
[No Abstract] [Full Text] [Related]
5. A new polymethylmethacrylate membrane for hemodialysis.
Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A
Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174
[TBL] [Abstract][Full Text] [Related]
6. Long-term multicentre study on beta 2-microglobulin removal by PMMA BK membrane.
Arakawa M
Nephrol Dial Transplant; 1991; 6 Suppl 2():69-74. PubMed ID: 1866073
[TBL] [Abstract][Full Text] [Related]
7. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
Saito A; Gejyo F
Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
[TBL] [Abstract][Full Text] [Related]
8. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis.
Küchle C; Fricke H; Held E; Schiffl H
Am J Nephrol; 1996; 16(6):484-8. PubMed ID: 8955759
[TBL] [Abstract][Full Text] [Related]
9. Behavior of beta 2-microglobulin (B2-m) serum levels in uremic patients.
Mioli VA; Balestra E; Bibiano L; Dellabella S; Fanciulli E; Gaffi G; Perilli A; Petroselli F; Ricciatti AM; Carletti P
Int J Artif Organs; 1994 Nov; 17(11):576-80. PubMed ID: 7744516
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of protein adsorbable membranes--long-term clinical effects and analysis using a proteomic technique.
Aoike I
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v13-9. PubMed ID: 17586841
[TBL] [Abstract][Full Text] [Related]
11. Beta2-microglobulin and amyloidosis.
Drüeke TB
Nephrol Dial Transplant; 2000; 15 Suppl 1():17-24. PubMed ID: 10737162
[TBL] [Abstract][Full Text] [Related]
12. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.
Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
Nephrol Dial Transplant; 2016 Apr; 31(4):595-602. PubMed ID: 26206763
[TBL] [Abstract][Full Text] [Related]
13. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
Schiffl H
Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
[TBL] [Abstract][Full Text] [Related]
14. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
15. [Carpal cysts in hemodialysis patients].
Viglietta G; Pavlica P; Dalla Rovere S; Santoro A; Spongano M; Ferrari G
Radiol Med; 1989 Oct; 78(4):305-10. PubMed ID: 2687960
[TBL] [Abstract][Full Text] [Related]
16. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
[TBL] [Abstract][Full Text] [Related]
17. Carpal tunnel surgery as proxy for dialysis-related amyloidosis: results from the Japanese society for dialysis therapy.
Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
Am J Nephrol; 2014; 39(5):449-58. PubMed ID: 24819459
[TBL] [Abstract][Full Text] [Related]
18. Case control study on dialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA Registry.
Brunner FP; Brynger H; Ehrich JH; Fassbinder W; Geerlings W; Rizzoni G; Selwood NH; Tufveson G; Wing AJ
Nephrol Dial Transplant; 1990; 5(6):432-6. PubMed ID: 2122319
[TBL] [Abstract][Full Text] [Related]
19. [Carpal tunnel syndrome in chronic hemodialysis patients].
Mbarki H; Akrichi A; Lazrak A; Maaroufi C; El Midaoui A; Tachfouti N; Jellouli W; Arrayhani M; Belahsen MF; Sqalli T
Pan Afr Med J; 2013; 14():19. PubMed ID: 23504584
[TBL] [Abstract][Full Text] [Related]
20. Dialysis-related carpal tunnel syndrome in the past 40 years.
Hatano M; Kitajima I; Yamamoto S; Nakamura M; Isawa K; Suwabe T; Hoshino J; Sawa N; Ubara Y
Clin Exp Nephrol; 2022 Jan; 26(1):68-74. PubMed ID: 34415463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
